Literature DB >> 15450002

Cardiovascular risk factors and endothelial dysfunction.

Anthony S Wierzbicki1, Philip J Chowienczyk, John R Cockcroft, Sally E Brett, Gerald F Watts, B Stephen Jenkins, James M Ritter.   

Abstract

Endothelial dysfunction is a feature of atherosclerosis and is associated with CHD (coronary heart disease) risk factors. This study aimed to determine the relationship between the degree of endothelial dysfunction and calculated cardiovascular risk. Endothelial function, as determined by the ACh/NP (acetycholine/sodium nitroprusside response) ratio on brachial plethysmography, was compared with cardiovascular risk as calculated from the Framingham, PROCAM (Prospective Cardiovascular Munster) and MRFIT (Multiple Risk Factor Intervention Trial) algorithms in 246 (187 male) patients, including 44 (22%) with established CHD. Endothelial dysfunction correlated with the total number of risk factors (r2=0.22; P=0.002) and was related to LDL (low-density lipoprotein)-cholesterol in men and triacylglycerols (triglycerides) in women. The ACh/NP ratio correlated with the occurrence of diabetes, CHD and the LDL-cholesterol concentration (r2=0.58; P<0.001). Endothelial dysfunction was associated with presence of CHD on receiver-operating characteristic plot analysis (area=0.706+/-0.04; P=0.001). There was no correlation between ACh/NP ratio and CHD risk calculated with the Framingham algorithm in men, although both ACh and NP response correlated separately with risk in women. The endothelial ACh/NP ratio correlated with absolute risk in the PROCAM algorithm (r2=0.41; P<0.005). Intermediate results were obtained with MRFIT. Individual risk factors make different contributions to endothelial dysfunction compared with their role in risk calculators. The stronger relationship of endothelial dysfunction with PROCAM risk reflects the contribution of male sex, LDL-cholesterol and triacylglycerols to risk calculated by this algorithm.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15450002     DOI: 10.1042/CS20040078

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  10 in total

1.  Hypertension, inflammation and T lymphocytes are increased in a rat model of HELLP syndrome.

Authors:  Kedra Wallace; Rachael Morris; Patrick B Kyle; Denise Cornelius; Marie Darby; Jeremy Scott; Janae Moseley; Krystal Chatman; Babbette Lamarca
Journal:  Hypertens Pregnancy       Date:  2014-02       Impact factor: 2.108

2.  Novel gene regulatory networks identified in response to nitro-conjugated linoleic acid in human endothelial cells.

Authors:  Haocheng Lu; Jinjian Sun; Wenying Liang; Jifeng Zhang; Oren Rom; Minerva T Garcia-Barrio; Shengdi Li; Luis Villacorta; Francisco J Schopfer; Bruce A Freeman; Y Eugene Chen; Yanbo Fan
Journal:  Physiol Genomics       Date:  2019-05-10       Impact factor: 3.107

Review 3.  Fetoplacental vascular endothelial dysfunction as an early phenomenon in the programming of human adult diseases in subjects born from gestational diabetes mellitus or obesity in pregnancy.

Authors:  Andrea Leiva; Fabián Pardo; Marco A Ramírez; Marcelo Farías; Paola Casanello; Luis Sobrevia
Journal:  Exp Diabetes Res       Date:  2011-11-24

4.  Effects of 4-week administration of simvastatin in different doses on heart rate and blood pressure after metoprolol injection in normocholesterolaemic and normotensive rats.

Authors:  Jacek Owczarek; Magdalena Jasińska; Irena Wejman; Urszula Kurczewska; Daria Orszulak-Michalak
Journal:  Arch Med Sci       Date:  2012-02-29       Impact factor: 3.318

Review 5.  Cardiovascular Action of Insulin in Health and Disease: Endothelial L-Arginine Transport and Cardiac Voltage-Dependent Potassium Channels.

Authors:  Sebastián Dubó; David Gallegos; Lissette Cabrera; Luis Sobrevia; Leandro Zúñiga; Marcelo González
Journal:  Front Physiol       Date:  2016-03-15       Impact factor: 4.566

6.  Investigating the lowest threshold of vascular benefits from LDL cholesterol lowering with a PCSK9 mAb inhibitor (alirocumab) in healthy volunteers - a mechanistic physiological study (INTENSITY-LOW): protocol and study rationale.

Authors:  Michael S Kostapanos; Paul J Cacciottolo; Annette Hubsch; Holly Pavey; James Hurlock; Kaisa Maki-Petaja; Ian B Wilkinson; Joseph Cheriyan
Journal:  J Drug Assess       Date:  2019-10-09

7.  FKBPL is associated with metabolic parameters and is a novel determinant of cardiovascular disease.

Authors:  Andrzej S Januszewski; Chris J Watson; Vikki O'Neill; Kenneth McDonald; Mark Ledwidge; Tracy Robson; Alicia J Jenkins; Anthony C Keech; Lana McClements
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

8.  Concomitant administration of simvastatin with ivabradine in contrast to metoprolol intensifies slowing of heart rate in normo- and hypercholesterolemic rats.

Authors:  Jacek Owczarek; Magdalena Jasińska; Jarosław Drożdż; Daria Orszulak-Michalak
Journal:  Arch Med Sci       Date:  2012-07-04       Impact factor: 3.318

9.  Integration of suboptimal health status and endothelial dysfunction as a new aspect for risk evaluation of cardiovascular disease.

Authors:  Vitalii Kupaev; Oleg Borisov; Ekaterina Marutina; Yu-Xiang Yan; Wei Wang
Journal:  EPMA J       Date:  2016-09-12       Impact factor: 6.543

Review 10.  The "Hitchhiker's Guide to the Galaxy" of Endothelial Dysfunction Markers in Human Fertility.

Authors:  Daniele Santi; Giorgia Spaggiari; Carla Greco; Clara Lazzaretti; Elia Paradiso; Livio Casarini; Francesco Potì; Giulia Brigante; Manuela Simoni
Journal:  Int J Mol Sci       Date:  2021-03-04       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.